EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Clinical trials for EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boosts cancer drug in aggressive myeloma trial
Disease control Recruiting nowThis study tests whether low doses of radiation can make the drug elranatamab work better against a tough type of multiple myeloma that has come back or not responded to treatment. About 34 adults with extramedullary or paramedullary disease will receive radiation plus elranatama…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
Radiation boosts new drug against stubborn myeloma tumors
Disease control Recruiting nowThis study tests whether adding targeted radiation to the drug talquetamab can safely and effectively treat multiple myeloma that has spread to organs or soft tissues (extramedullary disease). About 20 adults with this difficult-to-treat condition will receive radiation to one tu…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for aggressive myeloma: testing a Triple-Threat drug combo
Disease control Recruiting nowThis study is testing a three-drug combination (MeziKD) for adults with multiple myeloma that has come back or stopped responding to other treatments and has spread to form tumors in soft tissues or organs. The goal is to see if this combination can shrink these tumors and contro…
Matched conditions: EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC